J E Aslan1,2,3, R A Rigg1, M S Nowak1,4, C P Loren1, S M Baker-Groberg1, J Pang1, L L David5, O J T McCarty1,2,6. 1. Department of Biomedical Engineering, Portland, OR, USA. 2. Cell and Developmental Biology, Portland, OR, USA. 3. Knight Cardiovascular Institute, Portland, OR, USA. 4. Department of Medical Physics, Universite des Sciences et Technologies de Lille, Villeneuve d'Ascq, France. 5. Proteomics Shared Resource, Oregon Health & Science University, Portland, OR, USA. 6. Division of Hematology & Medical Oncology School of Medicine, Portland, OR, USA.
Abstract
BACKGROUND AND OBJECTIVES: The reversible acetylation of protein lysine ε-amino groups, catalyzed by lysine acetyltransferases and deacetylases, serves as a molecular switch in the orchestration of diverse cellular activities. Here, we aimed to investigate the role of lysine acetyltransfer in platelet function. METHODS AND RESULTS: Proteomics methods identified 552 acetyllysine (acK) modifications on 273 platelet proteins that serve as candidate substrates for lysine acetyltransferases. Bioinformatics analyses of the identified acK-modified platelet proteins supported roles for the lysine acetyltransferase p300 in the regulation of actin-mediated platelet processes. Biochemical experiments showed that platelets express p300, which is activated in an Src kinase-dependent manner upon platelet stimulation with the platelet glycoprotein VI agonist collagen-related peptide (CRP). Inhibition of platelet p300 abrogated CRP-stimulated lysine acetylation of actin, filamin, and cortactin, as well as F-actin polymerization, integrin activation, and platelet aggregation. Super-resolution visualization of platelet actin-rich adhesion structures revealed abundant acK protein colocalized with platelet actin cytoskeletal proteins. Inhibition of p300 blocked platelet filopodium formation and the spreading of platelets on fibrinogen and collagen surfaces. In whole blood, p300 inhibition prevented the formation of platelet aggregates under shear, suggesting a physiologic role for lysine acetyltransferase activity in platelet function. CONCLUSION: Together, our findings reveal lysine acetyltransfer to be a potential regulator of platelet actin dynamics, and potential roles for lysine acetylation in the molecular coordination of platelet activation and function.
BACKGROUND AND OBJECTIVES: The reversible acetylation of protein lysine ε-amino groups, catalyzed by lysine acetyltransferases and deacetylases, serves as a molecular switch in the orchestration of diverse cellular activities. Here, we aimed to investigate the role of lysine acetyltransfer in platelet function. METHODS AND RESULTS: Proteomics methods identified 552 acetyllysine (acK) modifications on 273 platelet proteins that serve as candidate substrates for lysine acetyltransferases. Bioinformatics analyses of the identified acK-modified platelet proteins supported roles for the lysine acetyltransferase p300 in the regulation of actin-mediated platelet processes. Biochemical experiments showed that platelets express p300, which is activated in an Src kinase-dependent manner upon platelet stimulation with the platelet glycoprotein VI agonist collagen-related peptide (CRP). Inhibition of platelet p300 abrogated CRP-stimulated lysine acetylation of actin, filamin, and cortactin, as well as F-actin polymerization, integrin activation, and platelet aggregation. Super-resolution visualization of platelet actin-rich adhesion structures revealed abundant acK protein colocalized with platelet actin cytoskeletal proteins. Inhibition of p300 blocked platelet filopodium formation and the spreading of platelets on fibrinogen and collagen surfaces. In whole blood, p300 inhibition prevented the formation of platelet aggregates under shear, suggesting a physiologic role for lysine acetyltransferase activity in platelet function. CONCLUSION: Together, our findings reveal lysine acetyltransfer to be a potential regulator of platelet actin dynamics, and potential roles for lysine acetylation in the molecular coordination of platelet activation and function.
Authors: Anna Michno; Anna Raszeja-Specht; Agnieszka Jankowska-Kulawy; Tadeusz Pawelczyk; Andrzej Szutowicz Journal: Clin Chem Date: 2005-07-14 Impact factor: 8.327
Authors: Nagalakshmi Nadiminty; Wei Lou; Soo Ok Lee; Xin Lin; Donald L Trump; Allen C Gao Journal: Proc Natl Acad Sci U S A Date: 2006-05-01 Impact factor: 11.205
Authors: Owen J T McCarty; Mark K Larson; Jocelyn M Auger; Neena Kalia; Ben T Atkinson; Andrew C Pearce; Sandra Ruf; Robert B Henderson; Victor L J Tybulewicz; Laura M Machesky; Steve P Watson Journal: J Biol Chem Date: 2005-09-29 Impact factor: 5.157
Authors: Anh T P Ngo; Marisa L D Thierheimer; Özgün Babur; Anne D Rocheleau; Tao Huang; Jiaqing Pang; Rachel A Rigg; Annachiara Mitrugno; Dan Theodorescu; Julja Burchard; Xiaolin Nan; Emek Demir; Owen J T McCarty; Joseph E Aslan Journal: Am J Physiol Cell Physiol Date: 2017-02-01 Impact factor: 4.249
Authors: Vitor F Martins; Jessica R Dent; Kristoffer Svensson; Shahriar Tahvilian; Maedha Begur; Shivani Lakkaraju; Elisa H Buckner; Samuel A LaBarge; Byron Hetrick; Carrie E McCurdy; Simon Schenk Journal: Am J Physiol Endocrinol Metab Date: 2019-03-19 Impact factor: 4.310
Authors: Anne D Rocheleau; Alexander R Melrose; Jennifer M Cunliffe; John Klimek; Özgün Babur; Samuel Tassi Yunga; Anh T P Ngo; Jiaqing Pang; Larry L David; Owen J T McCarty; Joseph E Aslan Journal: Proteomics Date: 2019-05-09 Impact factor: 3.984
Authors: Özgün Babur; Anh T P Ngo; Rachel A Rigg; Jiaqing Pang; Zhoe T Rub; Ariana E Buchanan; Annachiara Mitrugno; Larry L David; Owen J T McCarty; Emek Demir; Joseph E Aslan Journal: Am J Physiol Cell Physiol Date: 2018-02-07 Impact factor: 4.249
Authors: Anne D Rocheleau; Ayesha Khader; Anh T P Ngo; Colin Boehnlein; Cara McDavitt; Susan Lattimore; Michael Recht; Owen J T McCarty; Kristina M Haley Journal: Pediatr Res Date: 2018-01-03 Impact factor: 3.756
Authors: Kristoffer Svensson; Samuel A LaBarge; Abha Sathe; Vitor F Martins; Shahriar Tahvilian; Jennifer M Cunliffe; Roman Sasik; Sushil K Mahata; Gretchen A Meyer; Andrew Philp; Larry L David; Samuel R Ward; Carrie E McCurdy; Joseph E Aslan; Simon Schenk Journal: J Cachexia Sarcopenia Muscle Date: 2020-01-03 Impact factor: 12.910